Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3614_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
73 Мб
Скачать
SECTION 1 Pathophysiology and investigation ofcoronary artery disease58
)(
https://t.me/medicina_free
(a) (b)
(c) (d)
(e
Fig.7.1.1 Normal anatomy of the left (a– d) and right (e, f) coronary arteries as depicted by coronary angiography. (a)Aright anterior oblique (RAO)
cranial view of the left coronary artery (LCA) illustrates the proximal (p), mid (m), and distal (d)segments of the left anterior descending artery (LAD) after its takeoff from the left main coronary artery (LM). (b)An anteroposterior (AP) cranial view of the LCA shows septal (sept) and diagonal (diag) branches of the LAD. (c)An RAO caudal view of the LCA highlights the left circumflex artery (LCx) and its obtuse marginal branch (OM), also showing well the proximal LAD. (d)The LAO caudal view of the LCA is useful for demonstrating the bifurcation of the LM into the LAD and LCx. (e)The AP cranial view of the dominant right coronary artery (RCA) illustrates the vessel’s terminal branching into the right posterior descending artery (RPDA) and multiple right posterolateral arteries (RPL). (f)The LAO view of the RCA illustrates the vessel’s ‘C’- shaped course through the atrioventricular groove and its division into proximal (p), mid (m), and distal (d)segments.
Complications ofdiagnostic coronaryangiography
In the modern era, diagnostic coronary angiography can be accom­plished with a high degree of safety. Analysis of 1.1million patients without ST- elevation myocardial infarction undergoing diagnostic
coronary angiography in the United States from 2010 to 2011 re­vealed an overall adverse event rate of 1.35%. Key complications and their incidence include bleeding (0.49% within 72 hours), vascular complications requiring treatment (0.15%), stroke (0.17%, of which 9% were haemorrhagic), and new requirement for dialysis (0.14%). Non- risk adjusted mortality was 0.72%.
f)
(a) (b)
https://t.me/medicina_free
(c) (d)
7.1 Angiography 59
Fig.7.1.2 Coronary lesions as depicted by coronary angiography. Panel (a)illustrates an 80– 90% stenosis of the proximal left anterior descending
artery. Panel (b)illustrates a chronic total occlusion of the proximal right coronary artery, with distal filling via bridge collaterals. Panels (c)and (d)illustrate a heavily calcified bifurcation lesion of the distal left main coronary artery before (c)and after (d)contrast medium injection.
Common proceduralconsiderations
Key considerations in performance of diagnostic coronary angiog­raphy include the following:
1. Choice of vascular access. In comparison with femoral access, radial access reduces bleeding events and may improve patient comfort and time to ambulation, but may be associated with greater technical diculty, radiation exposure, and time, par­ticularly for less experienced operators.
2. Avoidance of contrast- induced nephropathy. Risk factors for contrast- induced nephropathy include hypotension, intra­aortic balloon counterpulsation, congestive heart failure, age greater than 75years, anaemia, diabetes mellitus, contrast media volume, and baseline impairment in renal function. In addition
Limitations ofangiography
Although qualitative coronary angiography maintains its role as the ‘gold standard’ for diagnosis of coronary artery disease, it has several limitations. ese include signicant inter- and intraobserver variability; unreliable prediction of functional sig­nicance, particularly for intermediate and diuse lesions; reli­ance on optimal acquisition technique; spatial distortion, overlap, and foreshortening due to compression of three- dimensional anatomy into a two- dimensional image; reliance on comparison to a ‘normal’ reference segment; and only indirect assessment of vessel wall and plaque composition.
Appropriateuse
to careful patient selection, parsimony in cineangiography and associated contrast usage is essential.
3. Minimization of radiation exposure. Both patients and oper- ators are subject to the stochastic and deterministic risks of ra­diation exposure encountered during coronary angiography. Techniques to keep exposure as low as reasonably achievable have been published, and centre on deliberate use of uoros­copy and cineangiography, distance, shielding, angles, collima­tion, and dosimetry.
Formal intersociety eort has gone into development of appro­priate use criteria for diagnostic cardiac catheterization, pro­viding useful algorithms for triage to coronary angiography. Broadly speaking, diagnostic coronary angiography tends to be appropriate for patients with denite or suspected acute coronary syndromes and symptomatic patients with a high pretest prob­ability of coronary artery disease or intermediate- to high- risk ndings on non- invasive testing.
SECTION 1 Pathophysiology and investigation ofcoronary artery disease60
https://t.me/medicina_free
REFERENCES
1. Coronary angiography. Lancet. 1966;1(7446):1084– 5.
2. Bruschke AV, Sheldon WC, Shirey EK, Proudt WL. A half century of selective coronary arteriography. J Am Coll Cardiol. 2009;54(23):2139– 44.
3. Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, etal. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel- eluting stent implantation (a TAXUS- IV sub study). Am J Cardiol. 2005;96(9):1242– 7.
4. Medina A, Suarez De Lezo J, Pan M. [A new classication of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59(2):183.
5. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, etal. e SYNTAX Score:an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219– 27.
6. Dehmer GJ, Weaver D, Roe MT, Milford- Beland S, Fitzgerald S, Hermann A, etal. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States:a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012;60(20):2017– 31.
7. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, etal. A simple risk score for prediction of contrast- induced nephropathy aer percutaneous coronary intervention:development and initial validation. J Am Coll Cardiol. 2004;44(7):1393– 9.
8. Chambers CE, Fetterly KA, Holzer R, Lin PJ, Blankenship JC, Balter S, etal. Radiation safety program for the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2011;77(4):546– 56.
9. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. e dissociation between clinical and angiographic ndings in ischemic heart disease. Circulation. 1995;92(8):2333– 42.
10. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, etal. ACCF/ SCAI/ AATS/ AHA/ ASE/ ASNC/ HFSA/ HRS/ SCCM/ SCCT/ SCMR/ STS 2012 appropriate use criteria for diagnostic catheterization:a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for oracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of oracic Surgeons. J Am Coll Cardiol. 2012;59(22):1995– 2027.
depth relates inversely to it. Currently available catheters range be­tween 20 and 45 MHz, providing an axial resolution of 100– 200 m and a penetration depth of up to 6mm. e cross- sectional images are provided in grayscale format and key anatomical struc­tures of the coronary artery or saphenous vein gra vessels wall can be identied.
Trilaminar vesselstructure
In the normal coronary artery vessel, IVUS can reliably visu­alize the luminal border of the intima and the interface between the media and adventitia, that is, the external elastic membrane (EEM) (Fig. 7.2.1). e media– intima separation, which is demar­cated by the internal elastic membrane, is oen not detectable by IVUS since the elastic membrane and the inner part of the media are very similar, thus blurring the interface. Also, it is not possible to dierentiate between adventitial and periadventitial structures.
Luminalstenosis
To measure luminal stenosis accurately, a proximal and distal reference segment with the least plaque burden should be iden­tied as well as the localization of the minimum lumen area. e lumen area stenosis is calculated as follows: reference segment lumen cross- sectional area (CSA) (average between proximal and distal reference lumen area) − minimum lumen CSA/ the reference lumen CSA.
Plaque burden andremodelling
As the thickness of the media cannot be reliably measured, the con­vention is to measure the intima– media thickness from the lumen border to the EEM. As for EEM CSA, the contour including the EEM is used. e plaque- media area is calculated by subtracting the lumen area from EEM CSA. e plaque burden is calculated by dividing the plaque– media area by the EEM CSA. Oen, a lesion is considered when a plaque burden is greater than 40% with a length greater than 1.5mm. Remodelling is based on early patho­logical observations and includes either an increase or a decrease in EEM during the process of atherosclerosis. When the EEM in­creases (i.e. as a response to an increasing plaque growth with the lumen remaining patent), it is termed positive remodelling. When the EEM area decreases, the term ‘negative’ remodelling is applied. In the clinical scenario, serial IVUS acquisitions are frequently not available and therefore, direct evidence of lesion remodelling is lacking. e magnitude and direction of the remodelling of an in­dividual lesion can be estimated by using the reference zone with the least plaque burden by dividing the EEM area of the lesion by the reference EEM area.
7.2 Intravascularultrasound
Lorenz Räber
Identification ofkey anatomicalstructures
e resolution of intravascular ultrasound (IVUS) is directly re­lated to the frequency of sound waves whereas the penetration
Plaquecomposition
IVUS characterizes the tissue according to its echogenicity. e echogenicity in comparison with the adventitia is described as echo­dense/ hyperechoic (bright), or echolucent/ hypoechoic. e deter­mination of plaque composition (mainly lipid vs other tissue) by greyscale IVUS alone was previously shown to be unreliable due to a low intra- and interobserver reproducibility. For this reason, autoregressive spectral analysis of IVUS backscattered data has been incorporated in conventional IVUS systems to facility image
(a) (b)
https://t.me/medicina_free
(c) (d)
7.2 Intravascularultrasound 61
Fig.7.2.1 Saphenous vein graft 6months after implantation (a, b) compared to native coronary artery vessel (c, d) obtained with a 20 MHz
transducer. The vein graft cross- section reveals moderate thickening of the intimal layer early after implantation. Surrounding tissue is not present in variance to the native coronary artery, where periadventitial tissue can be seen. Lumen line (red) and EEM (yellow).
interpretation as described elsewhere. IVUS is the most sensitive and specic intravascular tool to assess calcium. Calcium appears echo dense and causes acoustic shadowing, so that only the leading edge of calcium can be measured. e degree of calcication can pro­vide relevant information for the percutaneous coronary interven­tion (PCI) procedure. Fibrous plaques appear with an intermediate or high echogenicity depending on the density of brous material. High lipid content generally results in a low echogenicity and this characteristic of the acoustic signal led to the term ‘so’ plaque as a synonym for lipid- rich plaques. More recently, echo attenuation in the absence of calcium was correlated with the presence of a lipid or necrotic core. rombus is mostly localized intraluminally or directly attached to the lumen and shows an irregular appearance. No reliable criteria exist to dierentiate thrombus from other tissue components by IVUS.
Differences betweensaphenous vein grafts and native coronaryarteries
In contrast to native coronary arteries, vein gras have no side branches and no periadventitial tissue. Vein gras undergo mor­phological changes that are comparable to native arteries: that is, thickening of the intima with lipid deposition and medial
hypertrophy and measurements as described previously are simi­larly applicable. IVUS studies have shown that early intimal thick­ening occurs in angiographically normal saphenous vein gras already in the rst year aer gra surgery, a process related to the arterial pressure present (Fig. 7.2.1a,b). In one of the few serial IVUS studies in saphenous vein gra patients, lumen loss could be attributed not only to plaque growth but also negative remodelling, a nding that underscores that saphenous vein gras undergo re­modelling. Aparticular concern regarding PCI in saphenous vein gra procedures is the no- reow phenomenon. IVUS- detected intraluminal masses, multiple plaque ruptures, and degenerated saphenous vein gras emerged as predictors of no reow in a size­able cohort of 302 patients undergoing saphenous vein gra PCI. An example of a highly degenerated saphenous vein gra lesion is shown in Fig. 7.2.2.
Clinical applications ofintravascular ultrasound incoronary arterylesions
Severity ofcoronary artery disease stenosis:functional flow reserve versus IVUS- derived minimal lumenarea
Quantitative coronary analysis- derived percentage of diameter sten­osis or minimal lumen diameter is inferior when compared with the
SECTION 1 Pathophysiology and investigation ofcoronary artery disease62
(a)
https://t.me/medicina_free
d/e
b/c
(b) (c)
(d) (e)
Fig.7.2.2 Highly stenotic (a), degenerated saphenous vein graft 20years after implantation with a large eccentric plaque burden (b– e) at the site of
the minimal lumen area obtained by a 40 MhZ transducer. Asuperficial calcification with an acoustic shadowing can be seen in this mixed plaque. At a less stenotic position of the lesion, the plaque burden is lower and arterialization of the vessel anatomy can be appreciated. Lumen contour (red) and EEM (yellow).
Courtesy of Dr Kuramitsu and Dr Domei, Kokura Memorial Hospital, Japan.
gold standard functional ow reserve (FFR). Using IVUS to more precisely assess the minimal lumen area could potentially increase the diagnostic accuracy as compared to the gold standard FFR. Several studies have indeed shown that diagnostic precision can be improved when compared with quantitative coronary angiography, yet improving sensitivity and specicity to greater than 80% ap­pears impossible, so FFR testing should remain the gold standard for intermediate coronary artery lesions. An exception to this is the
le main artery where both angiographic assessment and FFR as­sessment can be challenging.
IVUS- guided coronary artery diseasetreatment
e assessment of lesion length, diameter, and the degree of cal­cication provides helpful information for the planning of the PCI procedure. Various parameters can be used to adequately se­lect stent diameter by applying an aggressive approach (i.e. 80%
7.3 Fractional flowreserve 63
https://t.me/medicina_free
of the EEM to EEM distance at the localization of the minimum CSA) to a more conservative approach (i.e. average of proximal
7.3 Fractional flowreserve
and distal lumen diameter). Following PCI, IVUS can detect ndings that are associated with an increased risk of restenosis and stent thrombosis such as lesion underexpansion, stent strut
Giovanni Ciccarelli, Emanuele Barbato, and Bernard De Bruyne
malapposition, dissections, and remaining disease burden at the stent edge. Recently, the superiority of IVUS versus angiography­guided PCI was shown by the IVUS- XPL randomized trial in-
Definition
cluding 1400 patients treated with drug- eluting stents for long coronary lesions. e use of IVUS resulted in a signicant reduc­tion of major adverse cardiovascular events, a dierence that was mainly driven by a reduction in the need for revascularizations of the target lesion.
IVUS imaging forprediction ofclinicalevents
Plaque burden is the most relevant independent predictor for fu­ture cardiovascular events and can be assessed and calculated as de­scribed previously. In the PROSPECT natural history study, plaque burden emerged as the most relevant independent correlate of major adverse cardiovascular events related to non- culprit lesions in acute coronary syndrome patients, resulting in a better discrimination as
Fractional ow reserve (FFR) is an index of the physiological sig­nicance of a coronary stenosis, dened as the ratio of maximal myocardial blood ow in the presence of the stenosis to the theor­etically normal maximal myocardial blood ow (i.e. in the absence of the stenosis)., is ow ratio can be calculated from the ratio of distal coronary pressure (Pd) to central aortic pressure (Pa) during maximal hyperaemia (Fig. 7.3.1). More practically, FFR indicates to what extent the epicardial segment can be responsible for myo­cardial ischaemia and, accordingly, FFR quanties the expected perfusion benet from revascularization by percutaneous coronary intervention (PCI). Very limited evidence exists on the role on FFR for coronary artery bypass gras (CABGs).
compared with minimal lumen diameter less than 4.0mm or the nding of a thin- cap broatheroma.
REFERENCES
1. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, etal. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of IVUS. J Am Coll Cardiol. 2001;37(5):1478– 92.
2. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316(22):1371– 5.
3. Pu J, Mintz GS, Biro S, Lee JB, Sum ST, Madden SP, etal. Insights into echo- attenuated plaques, echolucent plaques, and plaques with spotty calcication. J Am Coll Cardiol. 2014;63(21): 2220– 33.
4. Hozumi T, Yoshikawa J, Yoshida K, Akasaka T, Takagi T, Honda Y, etal. Use of intravascular ultrasound for in vivo assessment of changes in intimal thickness of angiographically normal saphenous vein gras one year aer aortocoronary bypass surgery. Heart. 1996;76(4):317– 20.
5. Hong YJ, Mintz GS, Kim SW, Lee SY, Kim SY, Okabe T, etal. Disease progression in nonintervened saphenous vein gra segments a serial intravascular ultrasound analysis. J Am Coll Cardiol. 2009;53(15):1257– 64.
6. Hong YJ, Jeong MH, Ahn Y, Mintz GS, Kim SW, Lee SY, etal. Intravascular ultrasound analysis of plaque characteristics and postpercutaneous coronary intervention catheterization outcomes according to the remodeling pattern in narrowed saphenous vein gras. Am J Cardiol. 2012;110(9):1290– 5.
7. Hong SJ, Kim BK, Shin DH, Nam CM, Kim JS, Ko YG, etal. Eect of intravascular ultrasound- guided vs angiography- guided everolimus- eluting stent implantation. JAMA. 2015;314(20): 2155– 63.
8. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, etal. A prospective natural- history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226– 35.
Practicalities
FFR is an invasive measurement obtained to complement coronary angiography or as part of a PCI. Intracoronary nitrates must be given before instrumenting the coronary arteries to alleviate epicar­dial vasomotor tone. Pa is typically obtained with a 5 or 6 F guide catheter positioned in the ostium of the coronary artery. Pd is meas­ured with a pressure monitoring guidewire. Aer equalization of the two pressures at the tip of the guide catheter, the pressure sensor is advanced in the distal part of the artery, at least 2cm distal to the stenosis to be measured. Maximal microvascular vasodilation can be obtained by intravenous infusion of adenosine (140 micrograms/ kg/ min) or by intracoronary bolus administration of adenosine (200 micrograms for the le coronary artery; 100 micrograms for the right coronary artery). While it is important to record the baseline pressure tracing, FFR can only be derived from the Pa and Pd at the time of maximal hyperaemia, that is, when microvascular resistance is minimal. Atypical example is shown in Fig. 7.3.2.
Fig. 7.3.2 presents a typical FFR recording. In this example FFR
equals 0.61 in the mid le anterior descending coronary artery (LAD). is means that the maximal myocardial perfusion reaches only 61% of what it should reach were the LAD normal.
Mainfeatures
Normal value. In a healthy epicardial artery (sometimes called
conductance arteries), since the resistance to ow is absent, Pd equals Pa. us, FFR equals 1 in each and every normal epicardial segment. In contrast to most other metrics in medicine there is no ‘range’ of normal values.
Ischaemic threshold. While the normal value of FFR equals 1, it
does not mean that all values below unity will be associated with
SECTION 1 Pathophysiology and investigation ofcoronary artery disease64
Fractional flow reserve is the ratio of maximal, hyperaemic myocardial flow in the presence of a lesion to the normal maximal, hyperaemic myocardial flow in the absence of the lesion:
Maximal hyperaemia is achieved by vasodilation of the coronary vasculature; subsequently, vascular resistances ar minimized and equal, and cancel out, while the venous pressure is negligible. The equation is finally expressed as:
FFR: fractional flow reserve,
: hyperaemic flow in the presence of a lesion, resistance of a territory perfused by a coronary artery with a stenosis, perfused by a normal coronary artery.
https://t.me/medicina_free
hyper
Q
FFR =
S hyper
Q
N
e
P
d
P
a
hyper
hyper
hyper
R
: microvascular resistance of a territory
S
S
: microvascular
S
FFR =
Pd : coronary pressure distal to the lesion, Pv : venous pressure, Pa : aortic pressure, Q
hyper
Q
: hyperaemic flow in the absence of lesions, R
N
Fig.7.3.1 FFR, a ratio of two flows, can be derived from two pressures during maximal hyperaemia. The complete derivation of these equation can be
found in the article by Pijls etal.1 while the simplified derivation can be found in a recent review.
Source data from Xaplanteris P etal. Catheter- based functional metrics of the coronary circulation. Journal of Nuclear Cardiology, 2017;24(4):1178– 89.
stress- induced ischaemia. e ischaemic threshold for FFR is around 0.80 with a narrow grey zone between 0.75 and 0.80. It is very unlikely to observe myocardial ischaemia associated with an FFR value greater than 0.80. When FFR is 0.80 or less, signs of ischaemia can be present during maximal exercise or pharmaco­logical stress. e latter is very likely when FFR is less than 0.75.
erefore, an FFR value of 0.80 is a widely accepted threshold to guide clinical decision- making. is threshold has been es­tablished by a sequential multi- testing technique and its clinical value has been largely conrmed., Embedded in this approach is the fact that a non- invasive comparator was considered posi­tive only if it was positive before revascularization and reversed to
3
Fig.7.3.2 Typical example of FFR measurement in a mid LAD in a 72- year- old woman. The baseline gradient is 14mmHg and increases to 33mmHg
during hyperaemia, corresponding to an FFR value of 0.61. Practically, this 0.61 value means that myocardial flow during maximal microvascular dilatation is only 61% of what it should reach if the epicardial artery were normal. This calculation can only be obtained during maximal hyperaemia. Also, it is interesting to notice that the increase in pressure gradient between rest and hyperaemia is relatively high, suggesting a preserved microvascular function. This further illustrates the importance of recording both resting and hyperaemic coronary haemodynamics.
7.3 Fractional flowreserve 65
1.0
FFR
No revascularization
https://t.me/medicina_free
negative aer revascularization. ese gures have been validated by clinical outcome data.
Myocardial mass. FFR specically relates the severity of the sten-
osis to the myocardial mass perfused by the coronary artery. For an identical degree of epicardial stenosis, the larger the myocar­dial mass, the larger the hyperaemic ow and in turn, the larger the gradient and the lower the FFR value.
Microcirculation. In patients with coronary artery disease, micro-
circulatory function is presumably oen abnormal. Yet, in con­trast to a general belief, the denition of FFR does not assume that the microcirculation is normal, but it quanties the extent to which the epicardial stenosis contributes to reduced myocardial perfusion, regardless of the status of the microvascular function in a given patient at a given point in time.
Collaterals. Distal coronary pressure during maximal hyperaemia
reects both antegrade and retrograde ow according to their re­spective contribution. Accordingly, FFR incorporates the collat­eral contribution to myocardial perfusion.
Haemodynamic. Within the ranges of blood pressure and heart
rate commonly encountered in the catheter laboratory, the value of FFR is very little inuenced by natural variations in systemic haemodynamics.
Beyond invasive FFR. Calculation of FFR values as derived from
plain coronary computed tomography (FFRCT) have recently been validated. is non- invasive approach allows for simul­taneous assessment of both coronary anatomy and physiology. Machine- learning algorithms keep improving the diagnostic precision of FFRCT even in calcied arteries. In addition, in pa­tients with stable chest pain, FFRCT has been shown to improve patient selection for coronary angiography. is approach might therefore introduce a true paradigm shi in the diagnostic work­up of patients with suspected coronary artery disease.
• Recently, several resting pressure- derived indexes such as in-
stantaneous wave- free ratio, resting full- cycle ratio, and diastolic pressure ratio have been introduced to assess the functional sig­nicance of coronary stenosis and can be used to guide percutan­eous treatment strategy in patients with coronary artery disease. However, no data are available on the role of resting indexes in guiding surgical revascularization.
No inducible
ischaemia
0.80
0.75
Inducible
ischemia
0.20
Ischaemia at rest
or necrosis
Fig.7.3.3 FFR cut- off values to guide revascularization strategy.
Revascularization
Multiple randomized clinical trials, corroborated the value of FFR­based decision- making. ey can be summarized as follows:
• When FFR is greater than 0.80 in stable lesions (i.e. stable pa-
tients or non- culprit stenosis of patients with unstable angina), clinical outcome is not improved by PCIs as compared to medical therapy. is has been conrmed in virtually all types of lesions and patient subsets, including le main stenosis, proximal LAD stenosis, small vessels, and bypass gras. In patients with multivessel disease, FFR- based treatment forms the basis of func- tionally complete revascularization as opposed to anatomically complete revascularization.
• In patients with acute coronary syndromes, there are no data so
far supporting the safety and ecacy of FFR in the ‘culprit’ lesion. From the presently available literature, FFR can be reasonably advocated— even at the acute phase— in the non- culprit lesions in patients with an acute coronary syndrome except in large ST­elevation myocardial infarctions (STEMIs) associated with ele­vated lling pressure and severely reduced ejection fraction. Several large randomized controlled trials are underway to clarify the role of FFR in patients with STEMIs and non- STEMIs.
• When FFR is less than 0.80 in stenoses located in proximal seg-
ments of large epicardial arteries, contemporary PCI is justied as it has been shown to improve patient outcomes as compared to medical therapy (Fig. 7.3.3)
Clinical outcomedata
In patients with stable chest pain, decision- making about treatment strategy should be based on anatomical and functional information on the coronary circulation. Nevertheless, a recent International Survey on Interventional Strategy survey underscored that inter­ventional cardiologists still prefer plain angiography, and its ‘50% diameter stenosis’ criteria, for decision- making, even in the absence of any budget and logistic constraints. Traditionally, the functional data is obtained by non- invasive testing which aim at detecting and localizing ‘myocardial ischaemia’. Yet, the diagnostic accuracy of diagnostic testing is overrated in the literature so that in clinical practice a sizable proportion of patients undergo coronary angiog­raphy and revascularization without prior useful functional infor­mation. erefore, obtaining ‘form and function’ at the same place and at the same time by the same operator is an appealing concept.
In summary, solid clinical outcome data from randomized con­trolled trials have established the role of FFR for bidirectional re­classication of angiographically visible stenoses and might replace non- invasive testing. Yet, the present data do not support the use of FFR in the culprit stenosis of STEMI and non- STEMI or in the non­culprit lesion of very large STEMI with haemodynamic compromise.
Fractional flow reserve and coronary artery bypassgrafting
ere are only scarce data available on the role of FFR- guidance of surgical revascularization., FFR- guided CABG is now under in­tense investigation.
Recently, two small- sized randomized trials have compared angiography- guided versus FFR- guided CABG, in multivessel dis­ease patients with similar results. e GRAFFITI trial showed that
SECTION 1 Pathophysiology and investigation ofcoronary artery disease66
https://t.me/medicina_free
functionally complete but anatomically incomplete CABG resulted in a similar 12- month gra patency rate and clinical outcomes des­pite a markedly simplied surgical strategy. e FARGO trial ran­domized 100 patients to FFR- based or angiography- based CABG and found that FFR- guided CABG had similar gra failure rates and clinical outcomes as angiography- guided CABG. e trial was stopped prematurely when less than 60% of the original sample size was enrolled. Due to the high rate of lost to follow- up, FARGO is very likely underpowered to detect even large dierences between groups. Also, almost 65% of the gras in FARGO where venous (not arterial) gras. In contrast, the IMPAG trial analysed 6- month func­tionality of 199 arterial gras in 68 patients with very high complete­ness of follow- up (94.1%) and no protocol deviation. In IMPAG, FFR predicted 6- month gra function signicantly better than angi­ography, with a cut- o of 0.78.
FFR has proven its worth in decision- making for PCI, in mul­tiple patient subgroups. In particular, recalculating the SYNTAX score by only incorporating ischaemia- producing lesions (‘func­tional SYNTAX score’) as determined by FFR decreases the number of higher- risk patients and better discriminates risk for adverse events in patients with multivessel coronary artery disease under­going PCI. Yet, larger studies are needed to understand how these conclusions might apply to CABG and to dene the role of FFR in guiding the treatment of patients with three- vessel coronary artery disease. It is important to note that the expected consequences of PCI of an FFR- insignicant lesion are very dierent from the con­sequences of bypass graing to a coronary artery with a non- ow­limiting native stenosis. In the former, major adverse cardiac and cerebrovascular event rates are increased, since the consequence of failure of an ‘unnecessary’ stent is restenosis or occlusion, leading to recurrent angina and/ or myocardial infarction. ere is no evi­dence of such a negative consequence for CABG in this scenario, since the closure of an ‘unnecessary’ coronary gra is usually a clin­ically silent event.
Conflicts ofinterest
e Cardiovascular Center Aalst receives grant support from Abbott, Boston Scientic, Biotronik, and St. Jude Medical and re­ceives consulting fees on behalf of Dr De Bruyne and Dr Barbato from St. Jude Medical, Opsens, and Boston Scientic outside of the submitted work. Dr De Bruyne is a shareholder for Siemens, GE, Bayer, Philips, HeartFlow, Edwards Life Sciences, Sano, and Omega Pharma.
REFERENCES
1. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood ow by pressure measurements for assessing functional stenosis severity before and aer percutaneous transluminal coronary angioplasty. Circulation. 1993;87(4):1354– 67.
2. De Bruyne B, Baudhuin T, Melin JA, Pijls NH, Sys SU, Bol A, etal. Coronary ow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 1994;89(3):1013– 22.
3. Xaplanteris P, Barbato E, De Bruyne B. Catheter- based functional metrics of the coronary circulation. J Nucl Cardiol. 2017;24(4):1178– 89.
4. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van ’t Veer M, etal. Fractional ow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213– 24.
5. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, etal. Fractional ow reserve- guided PCI for stable coronary artery disease. N Engl J Med. 2014;371(13):1208– 17.
6. Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, etal. Diagnosis of ischemia- causing coronary stenoses by noninvasive fractional ow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER- FLOW (Diagnosis of Ischemia- Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 2011;58(19):1989– 97.
7. Norgaard BL, Gaur S, Leipsic J, Ito H, Miyoshi T, Park SJ, etal. Inuence of coronary calcication on the diagnostic performance of CT angiography derived FFR in coronary artery disease:a substudy of the NXT Trial. JACC Cardiovasc Imaging. 2015;8(9):1045– 55.
8. Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, etal. Clinical outcomes of fractional ow reserve by computed tomographic angiography- guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease:the prospective longitudinal trial of FFR(CT):outcome and resource impacts study. Eur Heart J. 2015;36(47):3359– 67.
9. Lee JM, Choi KH, Park J, Hwang D, Rhee TM, Kim J, etal. Physiological and clinical assessment of resting physiological indexes. Circulation. 2019;139(7):889– 900.
10. Toth GG, Toth B, Johnson NP, De Vroey F, Di Serano L, Pyxaras S, etal. Revascularization decisions in patients with stable angina and intermediate lesions:results of the international survey on interventional strategy. Circ Cardiovasc Interv. 2014;7(6):751– 9.
11. Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, etal. Long- term clinical outcome aer fractional ow reserve­guided treatment in patients with angiographically equivocal le main coronary artery stenosis. Circulation. 2009;120(15):1505– 12.
12. Muller O, Mangiacapra F, Ntalianis A, Verhamme KM, Trana C, Hamilos M, etal. Long- term follow- up aer fractional ow reserve- guided treatment strategy in patients with an isolated proximal le anterior descending coronary artery stenosis. JACC Cardiovasc Interv. 2011;4(11):1175– 82.
13. Di Serano L, De Bruyne B, Mangiacapra F, Bartunek J, Agostoni P, Vanderheyden M, etal. Long- term clinical outcome aer fractional ow reserve- versus angio- guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass gras. Am Heart J. 2013;166(1):110– 8.
14 De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA,
Piroth Z, etal. Fractional ow reserve- guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991– 1001.
15. Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, etal. Fractional ow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3(12):1274– 81.
16. Pellicano M, De Bruyne B, Toth GG, Casselman F, Wijns W, Barbato E. Fractional ow reserve to guide and to assess coronary artery bypass graing. Eur Heart J. 2017;38(25):1959– 68.
17. Toth G, De Bruyne B, Casselman F, De Vroey F, Pyxaras S, Di Serano L, etal. Fractional ow reserve- guided versus
7.4 Optical coherencetomography 67
https://t.me/medicina_free
angiography- guided coronary artery bypass gra surgery. Circulation. 2013;128(13):1405– 11.
18. Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R. Gra Patency Aer FFR- Guided Versus Angiography- Guided CABG Trial (GRAFFITI). EuroIntervention. 2019;15(11)e999– 1005.
19. uesen AL, Riber LP, Veien KT, Christiansen EH, Jensen SE, Modrau I etal. Fractional ow reserve versus angiographically­guided coronary artery bypass graing. J Am Coll Cardiol. 2018;72(22):2732– 43.
20. Glineur D, Grau JB, Etienne PY, Benedetto U, Fortier JH, Papadatos S, etal. Impact of preoperative FFR on arterial bypass gra anastomotic function:the IMPAG trial. Eur Heart J. 2019;40(29):2421– 8.
21. Nam CM, Mangiacapra F, Entjes R, Chung I, Sels JW, Tonino
calcic (low- backscattering, sharply delineated signal- poor re­gions), and lipid- rich plaques (signal- poor lipid pools covered with brous cap) (Fig. 7.4.1b– d).
Haemodynamicsignificance
OCT has limited utility in assessment of haemodynamic signi­cance of coronary lesions. Minimal luminal area on OCT modestly correlates with fractional ow reserve in non- le main coronary ar­teries, reecting additional factors beyond the degree of stenosis that determine functional signicance. ere is a paucity of data cor­relating OCT- determined severity with fractional ow reserve and clinical outcomes in the le main coronary artery.
PAL, etal. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011;58(12):1211– 8
22. Zimmermann FM, De Bruyne B, Pijls NH, Desai M, Oldroyd KG,
Optical coherence tomography incoronary bypassgrafts
Park SJ, etal. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial:a comparison of fractional ow reserve- guided percutaneous coronary intervention and coronary artery bypass gra surgery in patients with multivessel coronary artery disease. Am Heart J. 2015;170(4):619– 26.
Perioperative assessment ofbypassconduits
OCT can guide intraoperative selection of conduits for coronary ar­tery bypass graing (CABG). Atherosclerotic lesions in radial ar­teries (RAs) and harvest- related injury (intimal trauma, thrombus) can be visualized by OCT. Intimal tears and medial dissections in RAs aer transradial coronary angiography are seen on OCT (Fig.
7.4.1e) and necessitate caution in using recently cannulated RAs for
CABG. e degree of spasm and vessel injury in RAs harvested with dierent methods (open vs endoscopic, harmonic scalpel vs
7.4 Optical coherencetomography
Keyvan Karimi Galougahi, Tomasz Roleder, Akiko Maehara, and Ziad A. Ali
Intravascular optical coherencetomography
Intravascular optical coherence tomography (OCT) is performed by a breoptic probe deployed through a catheter that emits near­infrared light and collects the reection. During acquisition, blood is temporarily displaced by infusion of ush media, resulting in high contrast between the lumen and vessel wall, allowing for accurate and automated measurement of vessel dimensions, not possible by other intravascular imaging modalities. is feature together with automated OCT angiography co- registration facilitates rapid as­sessment of coronary lesions and can guide revascularization by percutaneous coronary intervention (PCI). OCT has expanding applications in the management of stable coronary artery disease and acute coronary syndromes (ACS) in native coronaries and, po­tentially, in coronary bypass conduits.
electrocautery) can be assessed,, with signal attenuation in RAs (reecting lipid content) independently predicting RA spasm post CABG. Moreover, OCT is useful in assessing the distal anastomosis quality intraoperatively (Fig. 7.4.1f). In theory, OCT may be used prior to CABG to determine the suitability of distal coronary targets.
Postoperative assessment ofbypassgrafts
Saphenous veingraft
During the rst year post- CABG, saphenous vein gras (SVGs) undergo lumen loss due to a combination of wall thickening and negative remodelling. Aer 3years, thin- cap broatheroma (Fig.
7.4.1g) and adherent thrombus are evident. In older SVGs, athero-
sclerotic plaques become larger and aneurysmal dilations and cal­cication (Fig. 7.4.1h) may develop. Aer PCI on SVGs, in- stent restenosis develops faster, causes higher stenosis compared to de novo SVG lesions, and is evident earlier in drug- eluting versus bare­metal stents (Fig. 7.4.1h).
Left internal thoracicartery
Ten years post CABG, le internal thoracic artery gras show changes consistent with adaptive response to dierent ow dynamics in the coronary circulation, manifesting with intimal thickening and increased intima/ media ratio (Fig. 7.4.1i) and preservation of
Assessment ofnative coronary arterydisease
Morphologicalassessment
e trilaminar appearance on OCT represents the light scattering from the layers of the normal coronary artery (Fig. 7.4.1a). In cor­onary artery disease, there is a loss of this normal architecture along with common ndings of brous (high backscattering, signal rich),
endothelium- dependent vasodilation. A reduction in the thick­ness of the medial layer may reect the loss of vasa vasorum due to manipulation during CABG and new ow conditions.
Radialartery
Progressive remodelling of the RA has been shown with intravascular ultrasound but not yet with OCT (reduction in medial layer, increased luminal diameter, preserved endothelium- dependent vasodilation).